Leo E. Hollister
- Pharmacology top 0.05%
- Cannabis and Cannabinoid Research 53
- Treatment of Major Depression 45
- Toxicology top 0.05%
- Psychiatry and Mental health top 0.2%
- Schizophrenia research and treatment 74
- Electroconvulsive Therapy Studies 34
- Epilepsy research and treatment 33
- Cellular and Molecular Neuroscience top 0.5%
- Neurotransmitter Receptor Influence on Behavior 41
- Neuroscience and Neuropharmacology Research 36
- Biological Psychiatry top 1%
-
- Psychedelics and Drug Studies 29
- Co-authors
- H. K. GillespieJohn E. OverallStig AgurellHampton GillespieKenneth L. DavisJ.‐E. LindgrenJohn G. CsernanskyAnnika Ohlsson
- Partner nations
- United StatesSwedenJapan
In The Last Decade
Leo E. Hollister
361 papers receiving 9.2k citations
Peers
Comparison fields: 5 of 180
- Pharmacology 4.7k
- Toxicology 891
- Psychiatry and Mental health 2.6k
- Cellular and Molecular Neuroscience 3.1k
- Biological Psychiatry 360
Countries citing papers authored by Leo E. Hollister
This map shows the geographic impact of Leo E. Hollister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo E. Hollister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo E. Hollister more than expected).
Fields of papers citing papers by Leo E. Hollister
This network shows the impact of papers produced by Leo E. Hollister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo E. Hollister. The network helps show where Leo E. Hollister may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leo E. Hollister, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 10 | |
| 2 | 1999 | 2 | |
| 3 | 1996 | 18 | |
| 4 | 1990 | 2 | |
| 5 | 1990 | 3 | |
| 6 | 1990 | 1 | |
| 7 | 1990 | 1 | |
| 8 | 1988 | 2 | |
| 9 | 1987 | 26 | |
| 10 | Pharmacokinetics and metabolism of D-9-tetrahydrocannabinol: Relations to effects in man | 1986 | 3 |
| 11 | Mood disorders pharmacologic prevention of recurrences | 1985 | 127 |
| 12 | PLASMA CALCIUM AND PHOSPHATE DURING ALCOHOL INTOXICATION | 1983 | 5 |
| 13 | 1977 | 28 | |
| 14 | 1974 | 13 | |
| 15 | Indications for tricyclic antidepressant drugs. | 1971 | 5 |
| 16 | 1968 | 156 | |
| 17 | 1967 | 57 | |
| 18 | 1966 | 10 | |
| 19 | 1964 | 16 | |
| 20 | 1962 | 6 |
About Leo E. Hollister
Leo E. Hollister is a scholar working on Psychiatry and Mental health, Toxicology and Pharmacology, having authored 374 papers that have together received 10.7k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (74 papers), Cannabis and Cannabinoid Research (53 papers), Treatment of Major Depression (45 papers), Neurotransmitter Receptor Influence on Behavior (41 papers), Neuroscience and Neuropharmacology Research (36 papers), Electroconvulsive Therapy Studies (34 papers), Epilepsy research and treatment (33 papers) and Psychedelics and Drug Studies (29 papers). The work is most often cited by research in Pharmacology (4.7k citations), Toxicology (891 citations) and Psychiatry and Mental health (2.6k citations). Leo E. Hollister has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include H. K. Gillespie, John E. Overall, Stig Agurell, Hampton Gillespie, Kenneth L. Davis, J.‐E. Lindgren, John G. Csernansky, Annika Ohlsson, Jared Tinklenberg and A. Wahlén. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.